Disease-modifying therapies for MS exceed $1 million per QALY Clinical study 14 January 2013 Pages: 5 - 5
Cost effectiveness of adjuvant chemotherapy a generation game? Clinical study 14 January 2013 Pages: 7 - 7
Growth predicted for US healthcare spend over next decade Clinical study 14 January 2013 Pages: 7 - 7
UFH best bet for preventing postop VTE in ovarian cancer? Clinical study 14 January 2013 Pages: 7 - 7
Insulin: basal-bolus more cost effective than premixed for T2DM Clinical study 14 January 2013 Pages: 9 - 9
TDF-based ART best, but too costly for resource-poor Lesotho? Clinical study 14 January 2013 Pages: 10 - 10
Savings of €2 billion expected from new Spanish law on generics News item 14 January 2013 Pages: 11 - 11